Mutant of l1 protein of human papillomavirus type 18
AssigneesXiamen University, Xiamen Innovax Biotech Co., Ltd.
InventorsShaowei LI, Shuo SONG, Maozhou HE, Jingjie SHI, Ying GU, Ningshao XIA
Life of this patent
Estimating the term…
Loading patent…
AssigneesXiamen University, Xiamen Innovax Biotech Co., Ltd.
InventorsShaowei LI, Shuo SONG, Maozhou HE, Jingjie SHI, Ying GU, Ningshao XIA
Estimating the term…
The present invention relates to a mutated HPV18 L1 protein (or a variant thereof), a sequence encoding the same, a method for preparing the same, and a virus-like particle comprising the same, wherein the protein (or a variant thereof) and the virus-like particle can induce the generation of neutralizing antibodies against at least two HPV types (for example, HPV18 and HPV45, or HPV18, HPV45 and HPV59), and therefore can be used to prevent infection by said at least two HPV types, and a disease caused by said infection, such as cervical cancer and condyloma acuminatum. The invention further relates to the use of the protein and the virus-like particle in the manufacture of a pharmaceutical composition or a vaccine for preventing infection by said at least two HPV types, and a disease caused by said infection, such as cervical cancer and condyloma acuminatum.
A mutated HPV18 L1 protein or a variant thereof, wherein as compared with a wild type HPV18 L1 protein,
(canceled)
(canceled)
Dependencies are inferred from the claim text.